Mutual Funds

WOC Pharma and Healthcare Fund-Reg(G)
Equity | Very High | Equity - Sectoral Fund - Pharma & Health Care

16.88 +0.18
NAV(₹) as on 4/11/2026

1.07%
1D

18.56%
1Y

-
3Y

-
5Y

WOC Pharma and Healthcare Fund-Reg(G)
Growth Chart of the Scheme

Scheme Details
Expense Ratio: 2.72	Launch Date: 06 Feb 2024
Exit Load: NIL	AUM: ₹ 926.55 Crs
Lock-in: Nil	Investing Style: Large Growth
Portfolio Price To Book Value: 9.54	Min. Investment: SIP : ₹ 100.00 Lumpsum : ₹ 500.00
Scheme Benchmark: NA
Fund Manager: Ramesh Mantri ,Dheeresh Pathak ,Piyush Baranwal

FUND OBJECTIVE

The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.

LATEST ASSET & PORTFOLIO ALLOCATION		Debt		Others		Equity
as on 30/9/2026		3.15 %		6.12 %		90.73 %

TOP HOLDINGS

Divi's Laboratories Ltd.

8.36 %

Sun Pharmaceutical Industries Ltd.

7.11 %

Torrent Pharmaceuticals Ltd.

6.26 %

Laurus Labs Ltd.

3.91 %

Apollo Hospitals Enterprise Ltd.

3.75 %

Cipla Ltd.

3.68 %

Sai Life Sciences Ltd.

3.28 %

Ipca Laboratories Ltd.

2.88 %

Zydus Lifesciences Ltd.

2.81 %

Neuland Laboratories Ltd.

2.60 %

See All Holding

ALLOCATION BY MARKET CAP (Equity)

ALLOCATION BY RATING (Debt & Others)

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs

60.98 %

Hospital & Healthcare Servic

22.34 %

Chemicals

2.88 %

Plastic Products

1.84 %

Medical Equipment/Supplies/A

1.38 %

See All Sectors

PORTFOLIO CHARACTERISTICS (Debt)

No Data

5 YEAR HISTORY

Financial Year	2023-24	2024-25	2025-26
NAV (31/3/2026)	9.96	12.74	13.39
Net Assets (Rs Crores)	10,860.86	30,362.42	55,641.96
Scheme Returns(%)(Absolute)	-0.44	26.85	6.90
B'mark Returns(%)(Absolute)	NA	NA	NA
Category Rank	85/90	2/102	8/120

RISKOMETER
Level of Risk in the Scheme

Clients will understand that their principal will be at Very High risk.

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Fund Details	Inception Date	Aum(₹ Crs)	1Y	3Y	5Y	Since Inception
WOC Pharma and Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 16.88 +0.18	6/2/2024	₹ 926.55	18.56%	-	-	21.02%
PGIM India Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 11.96 +0.17	6/12/2024	₹ 130.33	18.07%	-	-	9.81%
Bajaj Finserv Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 11.74 +0.10	27/12/2024	₹ 405.14	18.06%	-	-	9.01%
Baroda BNP Paribas Health and Wellness Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 10.74 +0.13	27/6/2025	₹ 487.35	10.58%	-	-	5.44%
Bandhan Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 11.08 +0.11	28/11/2025	₹ 326.54	-	-	-	10.76%
Invesco India Pharma and Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 10.00 +0.25	7/9/2026	₹ 435.52	-	-	-	%
Kotak Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 17.01 +0.18	11/12/2023	₹ 825.14	23.56%	-	-	20.08%
Nippon India Pharma Fund(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 566.94 +5.48	5/6/2004	₹ 9,166.4	9.58%	17.78%	13.50%	19.72%
Tata India Pharma & Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 32.65 +0.39	28/12/2015	₹ 1,511.49	5.17%	17.86%	13.51%	11.51%
ITI Pharma & Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 18.01 +0.23	8/11/2021	₹ 266.05	9.54%	18.45%	-	12.50%